VANCOUVER, BC / April 10, 2018 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) today announced that the temporary warrant exercise price amendment expired at the close of business
VANCOUVER, BC / March 19, 2018 / CVR Medical Corp. The press release that follows is re-issued due to a typographical error in the access code of the original release (issued on March 16, 2018
VANCOUVER, BC / March 16, 2018 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) today announced that it will temporarily reduce the exercise price of its outstanding 2017 warrants
VANCOUVER, BC / March 7, 2018 / CVR Medical Corp. (TSX.V: CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) advisory staff member Dr. Phillip J. Bendick, PhD, has completed his second clinical report summarizing additional data
VANCOUVER, BC / February 27, 2018 / CVR Medical Corp. (TSX.V: CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) announces Internal Review Board (IRB) approval by The Cleveland Clinic, sanctioning CVR to conduct clinical trials using
VANCOUVER, BC / February 20, 2018 / CVR Medical Corp. (TSX.V: CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) announces the launch of pivotal clinical trials beginning Monday March 5, 2018 for the Carotid Stenotic Scan
VANCOUVER, BC / February 13, 2018 / CVR Medical Corp. (TSX.V: CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) announces placement of two additional wireless Carotid Stenotic Scan (CSS) devices into clinical trials at historic Methodist
VANCOUVER, BC / February 8, 2018 / CVR Medical Corp. (TSX.V: CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical” or “CVR”) has joined Canon Virginia, Inc. (CVI) at PLASTEC West (February 6 – 8, 2018), the largest
VANCOUVER, BC / February 6, 2018 / CVR Medical Corp. (TSX.V: CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical” or “CVR”) announces the placement of an initial order of touch panel PC’s for its “Carotid Stenotic Scan
VANCOUVER, BC / February 1, 2018 / CVR Medical Corp. (TSX.V: CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) announces the launch of their Pre-Pivotal Trial clinical substantiation phase for the “Carotid Stenotic Scan (CSS)” device. This
VANCOUVER, BC / January 31, 2018 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) announces that it intends to complete a private placement financing for gross proceeds of up to
VANCOUVER, BC / January 23, 2018 / CVR Medical Corp. (TSX.V: CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) announces the commencement of clinical data acquisition by the Carotid Stenotic Scan (CSS) device at the renowned Henry Ford
CVR Medical Corp. is a med-tech organization dedicated to the development and advancement of revolutionary technology at work within the healthcare sector. Specifically, The Carotid Stenotic Scan (CSS), a groundbreaking tool which will be used to assess Carotid Arterial health in a way which is unavailable to the patient, healthcare provider, and the payor within the current system. By leveraging intellectual property, market and industry know-how, and key strategic relationships, CVR Medical has entered into a trajectory which will revolutionize healthcare and dramatically improve clinical outcomes.
